Mesa Laboratories, Inc. (FRA:MLI)

Revenue by Product

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
Sterilization and Disinfection Control	75.12M
Sterilization and Disinfection Control Growth	16.27%
Clinical Genomics	52.59M
Clinical Genomics Growth	-15.59%
Calibration Solutions	47.76M
Calibration Solutions Growth	6.60%
Biopharmaceutical Development	40.71M
Biopharmaceutical Development Growth	-14.05%

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016
United States	106.40M
United States Growth	-9.28%
China	24.93M
China Growth	-3.35%
Other	84.86M
Other Growth	11.65%